Drew BG, Hamidi H, Zhou Z, Villanueva CJ, Krum SA, Calkin AC, Parks BW, Ribas V, Kalajian NY, Phun J, et al
A randomized, double-blind, placebo-controlled trial in 191 older adults (75 years) with moderate vitamin B 12 deficiency (serum cobalamin concentrations of 107-210 pmol/L) without anemia provided participants with 1 mg/day of cyanocobalamin for one year (94)
GHK-Cu, or copper tripeptide-1, is a delicate structure
Supportive treatment, complementary therapies for tetanus, paralysis and weakness
Future research should focus on refining these treatment modalities and expanding comparative studies to optimize B12 deficiency management strategies effectively
Now that we have forged links with the BSH we look forward to being involved in all manner of activities in the future